Teva Pounces On US Revlimid Opportunity With Four Strength-Offering

Israeli Firm Has Partnered With Natco; December 2015 Settlement Provides For Entry

 
• By Dean Rudge
  
Launch Button Finger Press
Teva and Natco have waited more than six years for the opportunity • Source: Olivier Le Moal / Alamy Stock Photo
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Generics

More from Products